Literature DB >> 21199719

Rituximab for uveitis.

Elisabetta Miserocchi, Irene Pontikaki, Giulio Modorati, Francesco Bandello, Pier Luigi Meroni, Valeria Gerloni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21199719     DOI： 10.1016/j.ophtha.2010.07.031

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  18 in total

Review 1.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 2.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Authors:  R W J Lee; A D Dick
Journal:  Eye (Lond)       Date:  2011-09-30       Impact factor: 3.775

Review 3.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 4.  New options for uveitis treatment.

Authors:  Yu He; Song-Bai Jia; Wei Zhang; Jing-Ming Shi
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

Review 5.  [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].

Authors:  A Heiligenhaus; C Tappeiner; K Walscheid; C Heinz
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

Review 6.  Current and future treatments for Behçet's uveitis: road to remission.

Authors:  Marina Mesquida; Blanca Molins; Victor Llorenç; María Victoria Hernández; Gerard Espinosa; Andrew D Dick; Alfredo Adán
Journal:  Int Ophthalmol       Date:  2013-06-01       Impact factor: 2.031

7.  Rituximab in refractory Vogt-Koyanagi-Harada disease.

Authors:  Rosa Dolz-Marco; Roberto Gallego-Pinazo; Manuel Díaz-Llopis
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-07-09

8.  Use of biologic agents in ocular manifestations of rheumatic disease.

Authors:  Courtney L Kraus; Susan M Culican
Journal:  Int J Rheumatol       Date:  2011-12-15

Review 9.  Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.

Authors:  Sirichai Pasadhika; James T Rosenbaum
Journal:  Biologics       Date:  2014-02-15

Review 10.  Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.

Authors:  Carla Gaggiano; Donato Rigante; Gian Marco Tosi; Antonio Vitale; Bruno Frediani; Salvatore Grosso; Claudia Fabiani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2019-12-10       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.